Trevi reports positive Phase 2b results, FDA alignment on two Phase 3 trials starting Q2 2026
Filed March 17, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 18, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade TRVI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 5:50 PM